Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes

NCT00099788 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

6560

Enrollment

INDUSTRY

Sponsor class

Conditions

Myocardial Ischemia

Interventions

DRUG: Ranolazine
DRUG: Placebo

Sponsor

Gilead Sciences

Collaborators

[object Object]